Connect with us

Cannabis

Huxley’s Visions Of The Future Could Be Here Sooner Than You Think – Open AI Guy “wants to revolutionize mental health care and addiction treatment with psychedelic drugs.”

[ad_1]

Personally, reading this, feels like i’ve had an ice cold arrow pierce my heart.

We’ve already got the likes of Atai’s Florian Brand singing from the same hymn sheet.

SOMA and AI combined sounds to me like an idea that barely evolved primates like our species should probably avoid for another 1000 years or so. Or until we can stop slaughtering one another wholesale, at the very minimum.

The Washington Post reports

The man bringing artificial intelligence to the masses through the viral chatbot ChatGPT wants to revolutionize mental health care and addiction treatment with psychedelic drugs.

Sam Altman, chief executive of OpenAI, is chairman of a start-up that aims to tap into the promise that psychedelic drugs have shown in clinical trials — and make them broadly available for people who suffer from mental health and drug-use disorders. The firm, Journey Colab, is partnering with a luxury rehab clinic, All Points North, to shepherd drugs like MDMA and psilocybin through late-stage trials and design a model for administering them to patients.

Jeeshan Chowdhury, Journey’s CEO, says such drugs are powerful tools, comparing them to performing complex surgeries. “Surgery is done in a safe environment in specialized facilities by highly experienced teams,” he said. “We aim to demonstrate that rehab centers … are the safest place for these interventions.”

Read More

https://www.washingtonpost.com/business/2023/04/22/sam-altman-psychedelics-mental-health/

 

[ad_2]

Sean Hocking

Source link